SEMGLEE (insulin glargine injection) is a sterile solution for subcutaneous use. Insulin glargine is a recombinant human long-acting insulin analog.
SEMGLEE (Insulin Glargine)
Indicated to improve glycemic control in adults and pediatric patients from 6 years old with type 1 diabetes mellitus and in adults with type 2 diabetes mellitus.
Limitations of use: SEMGLEE is not recommended for the treatment of diabetic ketoacidosis.
What is SEMGLEE?
SEMGLEE is a once-daily long-acting insulin analogue (100 units/ml).
SEMGLEE is available as a solution for injection in 10ml multiple dose vials or in 3ml single-patient-use prefilled injector pens.
Semglee (Insulin Glargine) aids in the control of diabetes mellitus in cats. This medication works to regulate your diabetic cat’s blood sugar. When blood glucose levels are normal, your cat’s body will work efficiently and diabetes symptoms will be fewer.
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
The technical storage or access that is used exclusively for statistical purposes.The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.